Iran’s drug squeeze hits transplant care as key anti-rejection pill runs out

A patient lies on a bed at Masih Daneshvari Hospital in Tehran on December 1, 2025, as unhealthy air pollution strains vulnerable groups
A patient lies on a bed at Masih Daneshvari Hospital in Tehran on December 1, 2025, as unhealthy air pollution strains vulnerable groups

Iran is facing a fresh shortage of the brand-name anti-rejection drug Myfortic with pharmacies halting distribution in several cities and clinicians warning that forced switches to substitutes could endanger a minority of kidney-transplant patients.